Fracture News and Research

RSS

Positive data from Tarsa's OSTORA Phase III trial on postmenopausal osteoporosis

Tarsa Therapeutics today presented positive safety and efficacy data from its Phase III ORACAL trial of OSTORA-, the company's oral recombinant salmon calcitonin tablet in development for the treatment of postmenopausal osteoporosis.

19 Sep 2011

FDA advisory panel suggests warning for bisphosphonates but does not specify wording

Two independent advisory panels to the Food and Drug Administration (FDA) on Friday recommended increasing the cautionary language on the product labels of bone-building drugs taken by more than five million women in the United States. They did not however mention the exact words of the safety warnings and did not recommend limiting use of the drugs to a proposed five years. About 11 percent of women 55 and older take the drugs to prevent bone fractures.

12 Sep 2011

AOI Medical receives ISO 13485 Certification and CE marking approval for two VCF devices

AOI Medical, Inc. has received ISO 13485 Certification and CE marking approval for its Ascendx VCF Repair System and its Ascendx Acu-Cut Vertebral Augmentation System to treat vertebral compression fractures (VCF).

8 Sep 2011

IOF presents eight young investigator awards to researchers across the world

Eight IOF Young Investigator Awards were presented by the International Osteoporosis Foundation (IOF) to young researchers from Australia, China, India and Japan, in recognition of their outstanding work. The awards, valued at 1,000 USD each, were awarded to the highest scored abstracts by researchers under the age of 40.

7 Sep 2011

Kettering University's biodegradable magnesium alloy can repair traumatic bone injury

Repairing traumatic injury to a bone is possible, but current procedures require multiple surgeries and long-term recovery. Kettering University's Dr. Montserrat Rabago-Smith and her team of co-researchers are exploring the use of a magnesium orthotic alloy in severe trauma injuries where the distance between two halves of a bone can't be overcome by the human body's ability to regenerate and heal.

26 Aug 2011

Research roundup: Majority of Docs face malpractice claims; colonoscopies in older adults; 'overwhelming' Medicare advantage choices

The authors "analyzed malpractice data from 1991 through 2005 for all physicians who were covered by a large professional liability insurer with a nationwide client base" and found that "by the age of 65 years, 75% of physicians in low-risk specialties had faced a malpractice claim, as compared with 99% of physicians in high-risk specialties." Most of those claims did not result in a pyament.

20 Aug 2011

Amgen to present data from several Prolia studies at ASBMR 2011 meeting

Amgen today announced that it will present data from several Prolia (denosumab) studies, including eight year efficacy and safety data from a Phase 2 extension study in women with postmenopausal osteoporosis with low bone mineral density (BMD), at the 2011 American Society for Bone and Mineral Research (ASBMR) Annual Meeting in San Diego, Calif. from Sept. 16-20, 2011.

19 Aug 2011

$Dried plums can protect postmenopausal women against fractures, osteoporosis$

Dried plums can protect postmenopausal women against fractures, osteoporosis

When it comes to improving bone health in postmenopausal women — and people of all ages, actually — a Florida State University researcher has found a simple, proactive solution to help prevent fractures and osteoporosis: eating dried plums.

19 Aug 2011

IU scientist to investigate salubrinal drug against osteoporosis

An Indiana University scientist studying human bone growth has received a $2.6 million grant from the U.S. Department of Defense to study a chemical compound with potential to fight osteoporosis and accelerate broken bone healing.

18 Aug 2011

AHRQ's new Spanish-language guide on heart medications

A free, illustrated easy-to-read pamphlet that compares drugs for preventing heart attacks, heart failure or strokes in people with stable coronary heart disease is one of six new Spanish-language publications from HHS' Agency for Healthcare Research and Quality that help patients compare treatments for common illnesses.

16 Aug 2011

Neurologist care may improve quality of life for people with Parkinson's

People with Parkinson's disease who go to a neurologist for their care are more likely to live longer, less likely to be placed in a nursing home and less likely to break a hip than people who go to a primary care physician, according to a study published in the August 10, 2011, online issue of Neurology, the medical journal of the American Academy of Neurology.

11 Aug 2011

Current Medical Research & Opinion publishes new data on EVISTA for postmenopausal osteoporosis

Eli Lilly and Company today announced that data on EVISTA® (raloxifene HCl tablets) therapy for more than three years was published online in Current Medical Research & Opinion.

10 Aug 2011

Unigene second quarter revenue decreases to $2.5 million

Unigene Laboratories, Inc. a leader in the design, delivery, manufacture and development of peptide-based therapeutics announced second quarter financial results for the period ended June 30, 2011. The Company highlighted significant progress achieved in the second quarter with the continued execution of its turnaround strategy.

8 Aug 2011

$Strengths and limitations of FRAX in assessing fracture risk$

Strengths and limitations of FRAX in assessing fracture risk

FRAX- is a computer-based algorithm developed by the World Health Organization Collaborating Centre for Metabolic Bone Diseases to help predict the 10-year risk of fragility fracture. Now with 34 specific country models, FRAX is being used increasingly by physicians around the world to help assess their patients' fracture risk in the course of a clinical assessment.

3 Aug 2011

New generation antidepressants may increase risk of adverse outcomes in elderly

Older people taking new generation antidepressants are at more risk of dying or suffering from a range of serious health conditions including stroke, falls, fractures and epilepsy, a study involving researchers at The University of Nottingham has found.

3 Aug 2011

$VP, balloon kyphoplasty safe and effective for women with vertebral fractures$

VP, balloon kyphoplasty safe and effective for women with vertebral fractures

A working group of the International Osteoporosis Foundation (IOF) has issued a literature review of prospective controlled studies comparing the efficacy and safety of two minimally invasive techniques for vertebral augmentation after spine fracture: vertebroplasty (VP) and balloon kyphoplasty.

2 Aug 2011

Fracture News and Research

Positive data from Tarsa's OSTORA Phase III trial on postmenopausal osteoporosis

FDA advisory panel suggests warning for bisphosphonates but does not specify wording

AOI Medical receives ISO 13485 Certification and CE marking approval for two VCF devices

IOF presents eight young investigator awards to researchers across the world

Kettering University's biodegradable magnesium alloy can repair traumatic bone injury

Research roundup: Majority of Docs face malpractice claims; colonoscopies in older adults; 'overwhelming' Medicare advantage choices

Amgen to present data from several Prolia studies at ASBMR 2011 meeting

Dried plums can protect postmenopausal women against fractures, osteoporosis

IU scientist to investigate salubrinal drug against osteoporosis

AHRQ's new Spanish-language guide on heart medications

Neurologist care may improve quality of life for people with Parkinson's

Current Medical Research & Opinion publishes new data on EVISTA for postmenopausal osteoporosis

Unigene second quarter revenue decreases to $2.5 million

Strengths and limitations of FRAX in assessing fracture risk

New generation antidepressants may increase risk of adverse outcomes in elderly

VP, balloon kyphoplasty safe and effective for women with vertebral fractures

Groundbreaking biomechanical data on cervical spine injuries

Birth control pills may reduce woman's bone density

EC grants marketing authorization for Amgen's XGEVA to prevent skeletal-related events

Strength exercises boost bone density in postmenopausal women with osteoporosis

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News